Ringa V - Search Results

1

Estimated numbers of postmenopausal women treated by hormone therapy in France.

Gayet-Ageron A, Amamra N, Ringa V, Tainturier V, Berr C, Clavel-Chapelon F, Delcourt C, Delmas PD, Ducimetière P, Schott AM. Gayet-Ageron A, et al. Among authors: ringa v. Maturitas. 2005 Nov-Dec;52(3-4):296-305. doi: 10.1016/j.maturitas.2005.05.002. Epub 2005 Jun 13. Maturitas. 2005. PMID: 15955641 Free PMC article.

2

Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level.

Paquet S, Sassenou J, Ringa V, Czernichow S, Zins M, Ozguler A, Rigal L. Paquet S, et al. Among authors: ringa v. Nutr Metab Cardiovasc Dis. 2023 Jun;33(6):1254-1262. doi: 10.1016/j.numecd.2023.03.015. Epub 2023 Mar 28. Nutr Metab Cardiovasc Dis. 2023. PMID: 37088650

3

Determinants of hormonal replacement therapy in recently postmenopausal women.

Ringa V, Ledésert B, Gueguen R, Schiele F, Breart G. Ringa V, et al. Eur J Obstet Gynecol Reprod Biol. 1992 Jul 24;45(3):193-200. doi: 10.1016/0028-2243(92)90084-c. Eur J Obstet Gynecol Reprod Biol. 1992. PMID: 1511767

4

Menopause and perceived health status among the women of the French GAZEL cohort.

Ledésert B, Ringa V, Bréart G. Ledésert B, et al. Among authors: ringa v. Maturitas. 1994 Dec;20(2-3):113-20. doi: 10.1016/0378-5122(94)90006-x. Maturitas. 1994. PMID: 7715462

5

Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.

Ringa V, Ledésert B, Bréart G. Ringa V, et al. Osteoporos Int. 1994 Jan;4(1):16-20. doi: 10.1007/BF02352256. Osteoporos Int. 1994. PMID: 8148567

6

Use of hormone replacement therapy: women's representations of menopause and beauty care practices.

Fauconnier A, Ringa V, Delanoë D, Falissard B, Bréart G. Fauconnier A, et al. Among authors: ringa v. Maturitas. 2000 Jun 30;35(3):215-28. doi: 10.1016/s0378-5122(00)00130-4. Maturitas. 2000. PMID: 10936738

7

Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?

Vercambre MN, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F, Ringa V, Berr C. Vercambre MN, et al. Among authors: ringa v. Am J Epidemiol. 2007 Dec 15;166(12):1451-60. doi: 10.1093/aje/kwm162. Epub 2007 Aug 13. Am J Epidemiol. 2007. PMID: 17698505

8

Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.

Ringa V, Fritel X, Varnoux N, Zins M, Piault S, Quelen C. Ringa V, et al. Maturitas. 2007 Nov 20;58(3):216-25. doi: 10.1016/j.maturitas.2007.08.008. Epub 2007 Oct 4. Maturitas. 2007. PMID: 17919857

9

Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006.

Ringa V, Fritel X, Varnoux N, Zins M, Quelen C, Bouyer J. Ringa V, et al. Fertil Steril. 2010 Sep;94(4):1387-1391. doi: 10.1016/j.fertnstert.2009.07.1001. Epub 2009 Sep 11. Fertil Steril. 2010. PMID: 19748086 Free article.

10

[Characteristics and determinants of initiation of premenopausal use of oral progestagens in the French E3N cohort].

Fabre A, Fournier A, Mesrine S, Ringa V, Clavel-Chapelon F. Fabre A, et al. Among authors: ringa v. J Gynecol Obstet Biol Reprod (Paris). 2010 Jun;39(4):310-7. doi: 10.1016/j.jgyn.2010.03.011. Epub 2010 May 7. J Gynecol Obstet Biol Reprod (Paris). 2010. PMID: 20452148 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters